EUCTR2016-003551-30-DE进行中（未招募）1 期
Modeling of the impact of a PCSK9 inhibition on lipoproteins in patients with dyslipidemia
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Age >=18
- •written consent
- •Criteria for a therapy with PSCK9 inhibitors are given
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •1.severe Liver-disease g (Child-Pugh C)
- •2. severe renal insufficiency
- •3.TSH not im reference range
- •4. uncontrolled aterial hypertension: Diastolic RR >=105 mmHg and/or systolic RR >=160 mmHg.
- •5.alcohol abuse or other drug abuse (except smoking)
- •6. blood donation within the last 6 weeks before the screening
- •7. Patients with a severe acute disease
- •8.HbA1c > 8.0%
- •9. Other important severe internistic diseases, which may alter the lipidmetabolism
- •10.hypersensitivity against the substance
- •11.pregnancy oder planned pregnancy and lactation period
研究者
相似试验
已完成
4 期
Modelling the impact of PCSK9 inhibitors on lipoproteins in patients with dyslipidemiaE78.5Hyperlipidaemia, unspecifiedDRKS00011663niversitätsklinikum Freiburg30
招募中
不适用
Impact of PCSK9 Inhibitor on the Characteristics of Lipid-rich Coronary Plaques Assessed by Near-infrared SpectroscopyIschemic Heart DiseaseJPRN-UMIN000040318Gifu Heart Center50
尚未招募
Unknown
The early administration of PCSK9 inhibitors in patients with acute ischemic stroke and its impact on the prognosis of stroke and changes in lipid profilesDiseases of the circulatory systemKCT0009238Asan Medical Center200
已完成
不适用
Effect of PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitor on long term outcomes in patients with acute myocardial infarction: multicenter randomized controlled trialAcute myocardial infarctionJPRN-UMIN000028730Kagawa Prefectural Central Hospital180
已完成
不适用
Effect of PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitor on acute events in patients with acute myocardial infarction: multicenter randomized controlled trialAcute myocardial infarctionJPRN-UMIN000028729Kagawa Prefectural Central Hospital180